Negative association of MC3R variants with weight and blood pressure in Cape Town pupils aged 11 - 16 years

South African Medical Journal

Volumn 101, Issue 6, 2011, Pages 417-420

  Yako, Yandiswa Y ^a   Fanampe, Biotumelo L ^b   Hassan, Shafick M ^b   Erasmus, Rajiv T ^a   van der Merwe, Lize ^c   Matsha, Tandi E ^b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^c UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MC3R GENE; MC4R GENE; METABOLIC SYNDROME X; OBESITY; RECEPTOR GENE; RESTRICTION MAPPING; SCHOOL CHILD; SCREENING TEST; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTH AFRICA;

ADOLESCENT; BLOOD PRESSURE; CHILD; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OBESITY; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 79958049783     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998;280:1374-1377.
2. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science 1998;280(5368):1371-1374.
3. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348(12):1085-1095.
4. Carroll L, Voisey J, van Daal A. Gene polymorphisms and their effects in the melanocortin system. Peptides 2005;26:1871-1885.
5. Mencarelli M, Walker GE, Maestrini S, et al. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum Genet 2008;16(5):581-586.
6. Gotoda T, Scott J, Aitman TJ. Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin. Diabetologia 1997;40:976-979.
7. Lee YS, Poh LK, Kek BL, Loke KY. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 2007;56(10):2622-2630.
8. Reddy S, Resnicow K, James S, Kambaran N, Omardien R, Mbewu A. Underweight, overweight and obesity among South African adolescents: results of the 2002 National Youth Risk Behaviour Survey. Public Health Nutr 2009;12(2):203-207.
9. Matsha T, Hassan S, Bhata A, et al. Metabolic syndrome in 10-16-year-old learners from the Western Cape, South Africa: Comparison of the NCEP ATP III and IDF criteria. Atherosclerosis 2009;205(2):363-365.
10. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. Br Med J 2000;320:1240-1251.
11. Vaisse C, Clement K, Durand E. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-262.
12. Schalin-Jäntti C, Valli-Jaakola K, Oksanen L, et al. Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord 2003;27(1):70-74.
13. Weide K, Christ N, Moar KM, et al. Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice. Physiol Genomics 2003;13(1):47-56.
14. Feng N, Young SF, Aguilera G, et al. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 2005;54:2663-2667.
15. Santoro N, Perrone L, Cirillo G, et al Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am J Clin Nutr 2007;85:950-953.
16. Li WD, Joo EJ, Furlong EB, et al. Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. Int J Obes Relat Metab Disord 2000;24:206-210.
17. Savastano DM, Tanofsky-Kraff M, Han JC, et al. Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor. Am J Clin Nutr 2009;90(4):912-920.
18. Butler AA, Cone RD. The melanocortin receptors: lessons from knock out models. Neuropeptides 2002;36:1-8.
19. Ni XP, Pearce D, Butler AA, et al. Genetic disruption of gamma-melanocyte stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest 2003;111:1251-1258.
20. Oosterom J, Nijenhuis WA, Schaaper WM, et al. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors. J Biol Chem 1999;274:16853-16860.
21. Garrison RJ, Kannel WB, Stokes J III, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987;16:235-251.
22. Ni XP, Butler AA, Cone RD, Humphreys MH. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones. J Hypertens 2006;24:2239-2246.
23. Greenfield JR, Miller JW, Keogh JM, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009;360(1):44-52.
24. Tao YX, Segaloff DL. Functional characterization of melanocortin-3 receptor variants identify a lossof-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab 2004;89(8):3936-3942.
25. Nollau P, Wagener C. On behalf of the IFCC Scientific Division, Committee on Molecular Biology Techniques. Methods for detection of point mutations: performance and quality assessment. Clin Chem 1997;43:1114-1128.